Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ionis Pharmaceuticals (IONS – Research Report), Adamas Pharmaceuticals (ADMS – Research Report) and Dynavax (DVAX – Research Report).
Ionis Pharmaceuticals (IONS)
William Blair analyst Myles Minter maintained a Hold rating on Ionis Pharmaceuticals on December 30. The company’s shares closed last Monday at $60.83.
According to TipRanks.com, Minter is ranked #304 out of 5773 analysts.
Currently, the analyst consensus on Ionis Pharmaceuticals is a Moderate Buy with an average price target of $67.00.
Adamas Pharmaceuticals (ADMS)
In a report released yesterday, Tim Lugo from William Blair maintained a Buy rating on Adamas Pharmaceuticals. The company’s shares closed last Monday at $4.05, close to its 52-week low of $3.35.
According to TipRanks.com, Lugo is a 5-star analyst with an average return of 13.2% and a 47.2% success rate. Lugo covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Collegium Pharmaceutical, and BioMarin Pharmaceutical.
Currently, the analyst consensus on Adamas Pharmaceuticals is a Strong Buy with an average price target of $14.07, which is a 250.0% upside from current levels. In a report issued on December 18, H.C. Wainwright also reiterated a Buy rating on the stock with a $10.00 price target.
William Blair analyst Matt Phipps reiterated a Buy rating on Dynavax today. The company’s shares closed last Monday at $5.57.
According to TipRanks.com, Phipps ‘ ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -10.4% and a 41.3% success rate. Phipps covers the Healthcare sector, focusing on stocks such as Pieris Pharmaceuticals, Autolus Therapeutics, and Kezar Life Sciences.
Currently, the analyst consensus on Dynavax is a Strong Buy with an average price target of $16.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.